Revised committee composition effective 21 April 2026
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indo Us Bio-Tech has issued a revised outcome of its 10 July 2026 board meeting to clarify that the approved committee composition is effective from 21 April 2026, the date of the relevant director appointments and resignations. The Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee have been reconstituted with Ritaben Kikani, Shilpa Thumar, Jagdishkumar Ajudiya, and Hemanshi Soni. No other disclosures from the 10 July 2026 outcome are changed.
Procedural correction aligning committee effective dates with the original director changes. No material change for shareholders beyond governance housekeeping.